Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002682689 | SCV003537005 | uncertain significance | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | The c.1618A>G (p.S540G) alteration is located in exon 1 (coding exon 1) of the IRF2BPL gene. This alteration results from a A to G substitution at nucleotide position 1618, causing the serine (S) at amino acid position 540 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |